Rosiglitazone May Reduce Non-Melanoma Skin Cancer Risk in Taiwanese
BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1057-8
Full Text
Open PDFAbstract
Available in full text
Date
February 6, 2015
Authors
Publisher
Springer Science and Business Media LLC